3027046, 10.31083/FBL27046 Summary Keywords mitochondrial dysfunction, mitochondria-targeted antioxidants, muscle wasting pathways, oxidative stress, ROS, rotator cuff injury, supraspinatus atrophy Citation Pang E, Zou Y, Lu K, Li J, Chen X, Zhu Y, Wang T, Shi L and Kang H (2026) Mitochondrial ROS dyshomeostasis: a key driver of accelerated supraspinatus atrophy after rotator cuff injury
Exenatide once a week assisted more patients in reaching the majority of ADA-recommended therapeutic goals than treatment with sitagliptin, pioglitazone, or insulin glargine
Abdominal injections tend to have the most consistent absorption rate
Escalating dosage levels over four-week intervals allows cellular targets to adapt to sustained receptor activation
These results do not show that the compound is safe or effective in people or animals outside an approved research setting